Biblio
Export 2578 results:
Author [ Title
Filters: First Letter Of Last Name is S [Clear All Filters]
“Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.”, J Alzheimers Dis, vol. 54, no. 2, pp. 559-68, 2016.
, “TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1107-1117, 2017.
, “TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1027-1033, 2017.
, “TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1027-1033, 2017.
, “Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome.”, J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
, “Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.”, J Alzheimers Dis, vol. 49, no. 3, pp. 617-31, 2016.
, “Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1629-1642, 2021.
, “Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1629-1642, 2021.
, “Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 137-148, 2018.
, “Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.”, J Alzheimers Dis, vol. 79, no. 1, pp. 211-224, 2021.
, “Three-Repeat Tau with Grain-Like Structures and Distribution in an 83-Year-Old Man.”, J Alzheimers Dis, vol. 58, no. 3, pp. 681-685, 2017.
, “A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 1, pp. 107-115, 2018.
, “A three-dimensional human neural cell culture model of Alzheimer's disease.”, Nature, vol. 515, no. 7526, pp. 274-8, 2014.
, “Three VCP Mutations in Patients with Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1139-1146, 2018.
, “Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?”, J Alzheimers Dis, vol. 62, no. 1, pp. 335-346, 2018.
, “Is There a Characteristic Clinical Profile for Patients with Dementia and Sundown Syndrome?”, J Alzheimers Dis, vol. 62, no. 1, pp. 335-346, 2018.
, “A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1461-70, 2016.
, “A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.”, J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
, “TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.”, J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
, “TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.”, J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
, “TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.”, J Alzheimers Dis, vol. 56, no. 1, pp. 335-349, 2017.
, “Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.”, J Alzheimers Dis, vol. 71, no. 1, pp. 33-43, 2019.
, “Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study.”, J Alzheimers Dis, vol. 73, no. 2, pp. 707-714, 2019.
, “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
, “TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
,